Improving cholesterol treatment for blood donors with high cholesterol

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance cholesterol management among blood donors diagnosed with Familial Hypercholesterolemia (FH). It is a single-center, randomized trial comparing usual care with an implementation bundle intervention. Participants will undergo screening, receive follow-up calls, and complete virtual visits to assess their cholesterol levels and any adverse events. The study will involve blood and urine sample collection for eligibility and LDL-C measurement.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
* Age 18 to 75 years

Exclusion Criteria:

* Currently taking medication to lower cholesterol
* Taking any medication that can interact with statins
* Pregnancy
* Identified secondary cause of elevated lipids
* Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)

Where it's running

• UT Southwestern Medical Center
  Dallas, Texas, United States Recruiting

Study contacts

• Principal investigator: Amit Khera, MD — University of Texas Southwestern Medical Center
• Study coordinator: Amit Khera, MD
• Email: Amit.Khera@UTSouthwestern.edu
• Phone: 214.645.7500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tirzepatide for methamphetamine use disorder (phase 2)

  This phase 2 trial tests whether weekly tirzepatide injections can help adults with moderate to severe methamphetamine use disorder reduce use and improve outcomes compared with placebo.

  Recruiting Phase 2 University of Texas Southwestern Medical Center · Los Angeles, California and 3 other locations · NCT07825857

• Do beverage cues drive craving in adults with AUD

  In adults with alcohol use disorder, this study tests whether different non-alcoholic beverage cues can trigger cravings differently when people see and smell them without drinking.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07788716

• How foot braces might help people with ataxia walk better

  This study tests whether wearing foot orthoses at home can improve gait and balance for adults with cerebellar ataxia.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07720700

• Personalized Ultrafractionated Stereotactic Radiotherapy with Perioperative FLOT for GEJ and Esophageal Cancer

  This trial tests adding a personalized, ultra-fractionated radiotherapy boost (PULSAR) to standard perioperative FLOT chemotherapy for patients with esophageal or gastroesophageal junction cancer to see if it can be used safely.

  Recruiting Phase 1 University of Texas Southwestern Medical Center · Dallas, Texas · NCT07700420

• Hemophilia A: comparing long-acting FVIII replacement vs non-FVIII therapy in kids

  This study tests whether children with moderate to severe Hemophilia A on long-acting FVIII or non-FVIII therapies form clots differently and develop small joint bleeds or early joint changes.

  Recruiting University of Texas Southwestern Medical Center · Dallas, Texas · NCT07692217

• Adaptive dosing of immune therapy for hepatocellular carcinoma

  This trial tests whether changing the dosing schedule of nivolumab plus ipilimumab can help people with hepatocellular carcinoma who have Child-Pugh B liver disease.

  Recruiting Phase 2 University of Texas Southwestern Medical Center · Dallas, Texas · NCT07689175

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.